Skip to content

Embecta Corp. EMBC Finished goods

Finished goods at other companies

Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$65.92M-11.5%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$4.6M
ICU Medical logo
ICU MedicalICUI
$289.36M+9.9%
Insulet logo
InsuletPODD
Medtronic logo
MedtronicMDT
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO

Other financials

Income statement

See full
Revenue$221.8M-14.4%
Gross profit$127.8M-22.1%
Operating income$35.0M-44.4%
Net income-$4.1M-117%
EPS (diluted)-$0.07-118%

Balance sheet

See full
Cash & equivalents$193.4M-8.9%
Total debt$1.4B-12.5%
Total equity-$626.1M+15.0%
Total assets$1.0B-8.1%

Cash flow

See full
Operating cash flow$31.1M-2.2%
CapEx$500.0K+400%
Free cash flow$30.6M-3.5%

Valuation

See full
Market cap$193.41M-64.3%
Enterprise value$1.37B-24.8%
P/E1.7×-4.8×
P/S0.2×-0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin25.8%+9.7pp
Net margin10.7%+5.8pp
FCF margin19.6%+16.0pp

Returns & leverage

See full
Return on equity71.9%
Debt / equity
Current ratio2.5×0.0×

Where this comes from

Reported directly by Embecta Corp. in its filing.

Tagged under the XBRL concept us-gaap:InventoryFinishedGoods.

The official record: Embecta Corp.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Embecta Corp.'s finished goods.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Embecta Corp.'s finished goods?
Embecta Corp. (EMBC) reported finished goods of $126.8M in Q1 2026.
How has Embecta Corp.'s finished goods changed year-over-year?
Embecta Corp.'s finished goods increased by 7.5% year-over-year, from $118M to $126.8M.
What is the long-term trend for Embecta Corp.'s finished goods?
Over 4 years (2021 to 2025), Embecta Corp.'s finished goods has grown at a 8.6% compound annual growth rate (CAGR), from $83.9M to $116.9M.
What does finished goods mean?
Completed products ready for sale, valued at the lower of cost or net realizable value.